Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

The following is a summary of “Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study,” published in the February 2025 ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Focusing on gene replacement and CAR-T cell therapies, we discuss the main advances, limitations, and difficulties faced by the country in the production, approval, and incorporation of such products ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

In this Healio Video Perspective from Retina 2025, Adrienne W. Scott, MD, of Johns Hopkins University School of Medicine, discusses her research in sickle cell disease and sickle cell retinopathy.

Health workers in the eastern district of Budaka in Bukedi Sub-region have registered a decline in cases of sickle cell disease that had deeply affected families and communities in the district.

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count. Red blood cells are the most common cells in ...

In 2009 a team of biophysicists led by Anthony A. Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, were studying specklelike structures called P ...

The lentivirus vectors used to modify the T-cells are not capable of replication, thanks to a series of safety features to prevent replication, including spreading genetic material over small ...